In addition to our results, EGCG was previously shown to suppress indoleamine 2,3-dioxygenase (IDO), which can enhance immune escape by blocking the IFN-γ–induced JAK/PKC/STAT1 signaling pathway in oral cancer cells [24]. Here, IDO2 is linked to lip and oral cavity carcinoma.